Ask AI
ProCE Banner Series

Congress to Clinic: Myeloid Malignancies Clinical Advances Journal Club on Emerging MPN, MDS, and AML Data

Expert discussions and takeaways from key data presented at ASCO and EHA 2024 for myeloid malignancies

  AMA
Who Should Attend

This educational program is intended for hematologists, medical oncologists, and other healthcare professionals who treat patients with MDS, AML, and MPNs.

All Events

Congress to Clinic: Myeloid Malignancies Clinical Advances Journal Club on Emerging MPN, MDS, and AML Data

Past Events

June

26

2024

6:00 PM - 7:30 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Hematologic Malignancies.

Target Audience
This educational program is intended for hematologists, medical oncologists, and other healthcare professionals who treat patients with MDS, AML, and MPNs. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate emerging data in first-line treatment of low-risk MDS considering the potential impact of safety and efficacy results on clinical practice.
  • Apply the latest advances from studies to practice and guideline recommendations when individualizing a therapeutic strategy for the management of AML.
  • Plan an optimal therapeutic sequence for patients with MPNs based on the latest clinical trial data.
  • Determine if individual patients with MDS, AML, or MPNs are candidates for an ongoing investigational clinical trial and counsel patients on the investigational agents or drug combinations and the potential for trial enrollment.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Bristol-Myers Squibb.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191